Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGASYS and Ribavirin in HCV Genotype 2 or 3
NCT00077636Phase 4Completed
- Sponsor
- Roche
- Start
- Dec 2003
- Primary completion
- Mar 2006
- Modality
- Cytokines & Interferons
- Countries
- 9
01
Overview
A Phase 4 trial of pegylated interferon alpha in hepatitis C (HCV), sponsored by Roche. Started Dec 2003; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00077636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077636.